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Abstract
Background—The intertwining prescription opioid and heroin epidemic is a major public health 
problem in the United States, with increasing morbidity and mortality among persons who use 
these substances. We examined differences between persons who reported being hooked on 
prescription opioids prior to injecting for the first time and those who did not by demographics, 
injection and non-injection characteristics, and overdose.
Methods—Between June and December 2015, persons who inject drugs were recruited using 
respondent-driven sampling as part of the National HIV Behavioral Surveillance system in Denver, 
Colorado.
Results—Of 599 participants (median age, 40: IQR, 19–69; 71% male; 58% white, non-
Hispanic), 192 (32%) reported being hooked on prescription opioids before they injected for the 
very first time. Compared to participants who were not hooked before they injected, participants 
who reported being hooked were significantly more likely to be younger, more recent injectors, 
report a slightly older age at first injection, and report heroin as the first drug injected as well as 
the drug most frequently injected. Those who reported being hooked were also more likely to be 
more frequent users of benzodiazepines, non-injection prescription opioids, and non-injection 
heroin as well as report injecting on a daily or more than daily basis. Being hooked on prescription 
opioids prior to injection drug use was associated with a 1.55 (95% CI: 1.14, 2.10) fold increase in 
the risk of at least one overdose in the past 12 months.
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Conclusions—Being hooked on prescription opioids prior to injection might result in a higher 
risk profile for persons who inject drugs.
1. INTRODUCTION
In the United States, heroin use has increased significantly during the past decade.1 The 
increase in heroin use is mirrored by an increase in heroin-related overdose deaths, with a 
dramatic increase in 2014. The Centers for Disease Control and Prevention concludes that 
the 2014 overdose data “demonstrate that the United States’ opioid overdose epidemic 
includes two distinct but interrelated trends: a 15-year increase in overdose deaths involving 
prescription pain relievers and a recent surge in illicit opioid overdose deaths, driven largely 
by heroin.”2 A recent review outlines the complex and reciprocal nature of the intertwining 
prescription opioid and heroin epidemics.3 The review concludes that “fundamentally, 
prescription opioids and heroin are each elements of a larger epidemic of opioid-related 
disorders and death.”
While overdose deaths related to the interrelated prescription opioid and heroin epidemics 
are well documented in the National Vital Statistics System,2 less is known about nonfatal 
overdose events related to these intertwining epidemics. Existing studies of nonfatal 
overdose have focused primarily on heroin injectors with a handful of studies reporting on 
nonmedical use of prescription opioids. In a recent systematic review of the literature related 
to unintentional drug overdose worldwide published in 2015, only 5 of the 44 studies 
reporting on the experience of nonfatal overdoses examined prescription opioids in addition 
to heroin use.4–9 An additional study published after the systematic review showed that the 
odds of nonfatal overdose for those who injected both heroin and prescription opioids was 
2.46 (95% Confidence Interval: 1.81–3.30) compared to those who injected heroin alone.10
Given the complex nature of the intertwining prescription opioid and heroin epidemics, we 
sought to describe differences between those who initiated injection drug use after becoming 
hooked on prescription opioids and those who were not. We also examine the association 
between the two injection trajectories and the experience of nonfatal overdose in a sample of 
persons who inject drugs (PWID).
2. METHODS
2.1. National HIV Behavioral Surveillance System
The NHBS system was established in 2003 by the Centers for Disease Control and 
Prevention (CDC) to monitor risk behaviors among three populations at highest risk for HIV 
infection in the United States: gay, bisexual, and other men who have sex with men, persons 
who inject drugs (PWID), and heterosexuals at increased risk for HIV. NHBS involves 
rotating 12-month cycles of surveillance activities in these three populations. Surveillance 
activities include ethnographic formative research, an in-depth behavioral survey, and HIV 
testing during each cycle. The analyses presented in the current short communication are 
from the 2015 NHBS cycle among PWID in Denver, Colorado.
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2.2. Study Design and Protocol
Between June and December 2015, participants were recruited using respondent-driven 
sampling (RDS), a peer-referral sampling methodology.11 Each eligible participant was 
allowed to refer up to five persons from their network. Participants were instructed to recruit 
someone they knew who injects drugs and who they had seen in the past 30 days. Persons 
were eligible to participate if they were at least 18 years or older, had injected drugs during 
the preceding 12 months, resided in the Denver metropolitan statistical area, had not 
previously participated in the 2015 NHBS cycle, and were able to provide informed consent. 
Additional eligibility criteria included having physical evidence of recent injection (fresh 
track marks) or having current knowledge of drug preparation and injection technique and 
syringe description.
Verbal informed consent was obtained from eligible participants. Participants completed a 
standardized interviewer-administered behavioral risk survey using handheld computers.
The behavioral risk survey includes questions about sexual behaviors, injection behaviors, 
substance use, and HIV testing. In addition to the behavioral risk survey, which is the core 
NHBS survey and administered nationally across all sites, participants completed a shorter 
local questionnaire. Local questionnaires are developed during the formative research phase 
of NHBS, which includes interviews with key informants and focus groups to identify 
salient issue of concern or interest for the target population. The following question was 
included in the local questionnaire to capture information on nonmedical use of prescription 
opioids prior to injection: “Think back to the very first time that you injected any kind of 
drug. Were you hooked on painkillers, such as Oxycontin®, Vicodin®, morphine, or 
Percocet®, before you injected drugs for the very first time?” Similar to a group in Seattle, 
we used the term “hooked on” to avoid the word “dependence” which can be interpreted in 
different ways by non-clinicians. 12
Participants were also offered a rapid HIV test in addition to a rapid test for Hepatitis C 
Virus (HCV). Participants were given $35 for completing the survey, $35 for HIV and HCV 
testing, and $20 for each eligible person they recruited. All NHBS activities were voluntary 
and no names were collected. The study protocol was reviewed and approved by the 
Colorado Multiple Institutional Review Board.
2.3. Statistical Analysis
Chi-square (Χ2) statistics were calculated to assess differences based on being hooked on 
prescription opioids prior to injection drug use. Generalized linear models with log link and 
binomial error distribution were used to estimate prevalence ratios (PR) and associated 95% 
confidence intervals (CI) for the association between prior nonmedical use of prescription 
opioids and overdose. All analyses were conducted using StataSE Version 12 (StataCorp, 
College Station, TX).
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3. RESULTS
3.1. Characteristics of the Study Population
A total of 712 persons were screened for the 2015 cycle of NHBS in Denver, of whom 603 
(84.7%) were eligible to participate and 599 (84.1%) completed the local questionnaire. The 
final sample included 19 (3.2%) seed participants, all of whom were 29 years or younger. 
Younger seeds were purposefully recruited in an attempt to generate a sample which more 
accurately represents the PWID population. Approximately three quarters (70.4%) of 
participants were male and more than half (58.2%) identified as non-Hispanic white (Table 
1). Nearly one-quarter (22.0%) were 29 years old or younger. A large proportion of 
participants reported experiencing homelessness with 66.4% reporting being currently 
homeless and 15.1% reporting being homeless, but not in the past 12 months.
3.2. Nonmedical Use of Prescription Opioids Prior to Injection
Overall, 192 (32.1%) of participants reported being hooked on painkillers, such as 
Oxycontin, Vicodin, morphine, or Percocet, before they injected drugs for the very first time 
(Table 1). Compared to participants who did not report being hooked on prescription opioids 
before they injected, those who were hooked on prescription opioids were significantly more 
likely to be younger (under age 29), to be new injectors (i.e. less than 1 years since their first 
injection), to have injected heroin as their first drug, and to report heroin as the drug most 
frequently injected. Though those who reported being hooked on prescription opioids were 
more likely to be under the age of 29, they were also more likely to report a slightly older 
age of first injection with the mean age at first injection being 24.6 (95% CI: 23.5, 25.7) 
compared to a mean age of 22.4 (95% CI: 21.5, 23.2) for those who were not hooked on 
prescription opioids prior to their first injection.
3.3. Overdose Experience
Participants were asked about the number of times they had overdosed in the past 12 
months. A definition of overdose was not included in the question. Overall, 71 (12.0%) 
reported overdosing once in the past 12 months, 26 (4.3%) reported overdosing twice, and 
31 (5.2%) reported overdosing 3 or more times in the past 12 months (Table 2). Reporting 
being hooked on prescription opioids prior to injection drug use was associated with a 1.55 
(95% CI: 1.14, 2.10) fold increase in the risk of at least one overdose in the past 12 months. 
To control for factors that could potentially confound this association, we included variables 
that were associated with being hooked on prescription opioids prior to injection that might 
also be associated with the risk of overdose in a multivariate model. The association between 
being hooked and overdose was attenuated when we adjusted for age, years since first 
injection, non-injection use of heroin or prescription opioids, use of benzodiazepines, and 
participation in a treatment program in the past 12 months (prevalence ratio 1.36, 95% CI: 
0.97–1.91). On the other hand, participants who reported being hooked on prescription 
opioids prior to injection drug use were also more likely to report obtaining a take-home 
naloxone kit in the past 12 months (44.3% vs 26.5%, p<0.001).
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3.4. Non-injection Drug Use and Frequency of Injection
Participants who reported being hooked on prescription opioids prior to injection drug use 
were more likely to report more frequent (i.e. more than once a day) use of benzodiazepines, 
non-injection prescription opioids, and non-injection heroin, 13.6%, 13.1%, and 15.7% 
compared to those who were not hooked, 4.7%, 5.4%, and 7.7%, respectively (Table 2). 
Participants who reported being hooked on prescription opioids before injecting were also 
slightly more likely to report injecting one or more times a day compared to those who did 
not report being hooked (84.3% vs. 75%, p=0.024).
4. DISCUSSION
In our sample of current PWID, those who reported being hooked on prescription opioids 
prior to injection drug use were significantly more likely to be younger, more recent 
injectors, report a slightly older age at first injection, and report heroin as the first drug 
injected as well as the drug most frequently injected. Those who reported being hooked were 
also more likely to be more frequent users of benzodiazepines, non-injection prescription 
opioids, and non-injection heroin as well as report injecting one or more times a day. 
Perhaps because of this higher risk profile, participants who reported being hooked on 
prescription opioids prior to injecting were also more likely to report at least one overdose 
during the past 12 months. However, when we adjusted for potential confounding factors 
this association was slightly attenuated.
Several papers have described patterns of heroin use among those who have reported 
nonmedical use or injection of prescription opioids13–16 and a limited number have 
examined trajectories from nonmedical use of prescription opioids to heroin use.12,17,18 One 
study examining data from the National Survey on Drug Use and Health used discrete-time 
hazard models to estimate the age-specific hazard of heroin initiation in young adults. Study 
authors reported a hazard ratio of 13.1 (95% CI: 10.7, 16.0) for the association between 
nonmedical use of prescription opioids and heroin initiation with the peak age of heroin 
initiation being 17–18 years.19 However, the study does not specify the route of heroin 
administration. Another recent study described differences in initiation of heroin and 
prescription opioids by birth cohorts, but did not examine any characteristics beyond age.20
To our knowledge, this is the first paper to examine differences between those who reported 
being hooked on prescription opioids before they began injecting and those who were not in 
a large sample of PWID. Though the study from Peavy et al. also compares differences 
between those who reported being hooked on prescription opioids and those who were not, 
their question limited the response to those who were hooked prior to heroin injection.12 
While more than half of our participants who reported being hooked on prescription opioids 
before their first injection reported heroin as the first drug injected, a sizable portion 
reported cocaine and methamphetamine as the first injected drugs. This finding underscores 
the complexity of drug use patterns and suggests that the transition from prescription opioids 
to injection drug use is not limited to the injection of heroin or prescription opioids.
While the current study contributes to the existing literature by quantifying the differences 
between PWID who were hooked on prescription opioids before they began injecting and 
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those who were not, it is not without limitations. Because the survey was administered by an 
interviewer some participants might not have reported their behaviors accurately. Our results 
are limited to respondents in one urban city in the Western part of the United States and 
might not be generalizable to PWID in other parts of the country, or other countries.
Our findings that PWID who report being hooked on prescription opioids before they started 
injecting appear to have overall higher risk profiles point to the need for targeted 
interventions, such as provision of take-home naloxone kits and sterile injection supplies, to 
this group. In addition, research to identify factors that might accelerate or inhibit the 
transition from nonmedical use of prescription opioids to injection drug use is urgently 
needed.
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HIGHLIGHTS
▪ Dependence on prescription opioids prior to injection may result in higher 
risk profile.
▪ Prior dependence on prescription opioids is associated with increased 
overdose risk.
▪ Overdose prevention efforts should be targeted towards persons with high 
risk profiles.
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Table 1
Demographic and injection characteristics by status of prescription opioid misuse prior to first injection in a 
sample of persons who inject drugs, National HIV Behavioral Surveillance (NHBS), Denver, Colorado, 2015
Total Hooked
n (%)
Not
hooked
n (%)
p-
value
Overall* 599 192 (32.1) 407 (67.9)
Demographic Characteristics
Gender
  Male 421 (70.9) 124 (65.3) 297 (73.5) 0.039
  Female 173 (29.1) 66 (34.7) 107 (26.5)
Race/Ethnicity
  White, non-Hispanic 346 (58.2) 123 (64.4) 223 (55.2) 0.025
  Black, non-Hispanic 46 (7.7) 10 (5.2) 36 (8.9)
  Hispanic 151 (25.4) 49 (25.7) 102 (25.3)
  Other 52 (8.7) 9 (4.7) 43 (10.6)
Age
  18–29 132 (22.0) 67 (34.9) 65 (16.0) <0.001
  30–39 161 (26.9) 70 (36.5) 91 (22.4)
  40–49 144 (24.0) 30 (15.6) 114 (28.0)
  ≥50 162 (27.1) 25 (13.0) 137 (33.7)
Homeless in past 12 months
  No 110 (18.5) 32 (16.7) 78 (19.3) 0.514
  No, homeless longer than 12m 90 (15.1) 33 (17.3) 57 (14.1)
  Yes, currently homeless 396 (66.4) 126 (66.0) 270 (66.8)
Injection Characteristics
Age at first injection
  <= 14 70 (11.7) 10 (5.2) 60 (14.7) <0.001
  15–18 156 (26.0) 38 (19.8) 118 (29.0)
  19–22 113 (18.9) 36 (18.8) 77 (18.9)
  23–29 130 (21.7) 59 (30.7) 71 (17.4)
  >= 30 130 (21.7) 49 (25.5) 81 (19.9)
Years since first injection
  <=1 year 43 (7.2) 22 (11.5) 21 (5.2) <0.001
  2 – 3 years 61 (10.2) 31 (16.2) 30 (7.4)
  4 – 6 years 66 (11.0) 33 (17.2) 33 (8.1)
  7 – 10 years 78 (13.0) 39 (20.3) 39 (9.6)
  > 10 years 351 (58.6) 67 (34.9) 284 (69.8)
First drug injected
  Heroin 246 (41.1) 101 (52.6) 145 (35.6) <0.001
  Methamphetamine 173 (29.0) 24 (12.5) 149 (36.6)
  Cocaine 139 (23.2) 51 (26.6) 88 (21.6)
  Other 41 (6.8) 16 (8.3) 25 (6.1)
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Total Hooked
n (%)
Not
hooked
n (%)
p-
value
Most frequently injected drug past 12 months
  Heroin 351 (58.9) 141 (73.8) 210 (52.9) <0.001
  Methamphetamine 174 (29.2) 26 (13.6) 148 (36.5)
  Cocaine 17 (2.9) 4 (2.1) 13 (3.2)
  Other 54 (9.1) 20 (10.5) 34 (8.4)
NOTE:
*Subcategory total may not add to overall total due to missing data.
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Table 2
Overdose, participation in drug treatment, and non-injection drug use characteristics in the past 12 months by 
status of prescription opioid misuse prior to first injection in a sample of persons who inject drugs, National 
HIV Behavioral Surveillance (NHBS), Denver, Colorado, 2015
Total Hooked
n (%)
Not
hooked
n (%)
p-
value
Overall* 599 192 (32.1) 407 (67.9)
Overdose in past 12 months
  No 471 (78.6) 138 (71.9) 333 (81.8) 0.022
  Once 71 (12.0) 30 (15.6) 41 (10.1)
  Two or more times 57 (9.5) 24 (12.5) 33 (8.1)
Received take-home naloxone kit
  No 357 (59.6) 102 (53.1) 255 (62.7) <0.001
  Yes 193 (32.2) 85 (44.3) 108 (26.5)
  Don’t know what Naloxone is 49 (8.2) 5 (2.6) 44 (10.8)
Participated in drug treatment   
  Yes 243 (40.8) 93 (48.7) 150 (37.0) 0.007
  No 353 (59.1) 98 (51.3) 255 (63.0)
Tried to get treatment but unable   
  Yes 126 (21.1) 53 (27.8) 73 (18.0) 0.007
  No 470 (78.9) 138 (72.2) 332 (82.0)
Frequency of marijuana use   
  Once a day or more 219 (36.7) 62 (32.4) 157 (38.8) 0.428
  More than once a week 67 (11.2) 23 (12.0) 44 (10.9)
  Less than once a week 120 (20.1) 44 (23.0) 76 (18.8)
  Not in the past 12 months 190 (31.9) 62 (32.5) 128 (31.6)
Frequency of benzo use
  Once a day or more 45 (7.6) 26 (13.6) 19 (4.7) <0.001
  More than once a week 59 (9.9) 24 (12.6) 35 (8.6)
  Less than once a week 161 (27.0) 68 (35.6) 93 (23.0)
  Not in the past 12 months 331 (55.5) 73 (38.2) 258 (63.7)
Frequency of prescription opioid use
  Once a day or more 47 (8.0) 25 (13.1) 22 (5.4) <0.001
  More than once a week 63 (10.6) 28 (14.7) 35 (8.6)
  Less than once a week 164 (24.5) 63 (33.0) 101 (25.0)
  Not in the past 12 months 322 (54.0) 75 (39.3) 247 (61.0)
Frequency of non-injection heroin use
  Once a day or more 61 (10.2) 30 (15.7) 31 (7.7) <0.001
  More than once a week 35 (5.9) 13 (6.8) 22 (5.4)
  Less than once a week 127 (21.3) 55 (28.8) 72 (17.8)
  Not in the past 12 months 373 (62.6) 93 (48.7) 280 (69.1)
Frequency of injection
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Total Hooked
n (%)
Not
hooked
n (%)
p-
value
  More than once a day 395 (66.3) 143 (74.9) 252 (62.2) 0.024
  Once a day 70 (11.7) 18 (9.4) 52 (12.8)
  More than once a week 62 (10.4) 14 (7.3) 48 (11.9)
  Once a week or less 69 (11.6) 16 (8.4) 53 (13.1)
NOTE:
*Subcategory total may not add to overall total due to missing data.
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